Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gamidaeganghwal-tang (GMDGHT) is a traditional Korean herbal medicine (Hanbang) primarily utilized for the treatment of musculoskeletal disorders, including joint pain, stiffness, and inflammation. It is a modified version of the classical 'Daeganghwal-tang' formula, typically enriched with additional herbal components to enhance its therapeutic profile for degenerative conditions. GMDGHT is composed of multiple botanical extracts known for their analgesic and anti-inflammatory properties. Current clinical research, including multicenter randomized controlled trials, is focused on evaluating its efficacy, safety, and cost-effectiveness in patients with degenerative knee osteoarthritis (KOA). The formula is often administered in a standardized granule form to ensure consistency in clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gamidaeganghwal-tang.